|
MSL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.24074100888083E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04083408558608E-12 |
| Normal-vs-Stage2 |
7.612000E-04 |
| Normal-vs-Stage3 |
6.14339999982505E-07 |
| Normal-vs-Stage4 |
6.14279999977541E-07 |
| Stage1-vs-Stage2 |
3.018800E-01 |
| Stage1-vs-Stage3 |
1.430240E-01 |
| Stage1-vs-Stage4 |
7.052200E-01 |
| Stage2-vs-Stage3 |
9.818200E-01 |
| Stage2-vs-Stage4 |
2.913000E-01 |
| Stage3-vs-Stage4 |
1.740790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23914245320611E-13 |
| Normal-vs-AfricanAmerican |
7.587100E-04 |
| Normal-vs-Asian |
1.222200E-02 |
| Caucasian-vs-AfricanAmerican |
4.939000E-01 |
| Caucasian-vs-Asian |
1.125590E-01 |
| AfricanAmerican-vs-Asian |
1.000030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.58293386679043E-12 |
| Normal-vs-Female |
2.21449969473042E-10 |
| Male-vs-Female |
6.797600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.476250E-03 |
| Normal-vs-Age(41-60Yrs) |
1.91258120452176E-12 |
| Normal-vs-Age(61-80Yrs) |
2.829799727877E-10 |
| Normal-vs-Age(81-100Yrs) |
8.514300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.025400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.317000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.575630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.817800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.106030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.305400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.14880000032936E-07 |
| Normal-vs-Grade 2 |
3.72446518071001E-12 |
| Normal-vs-Grade 3 |
6.63059995797965E-09 |
| Normal-vs-Grade 4 |
4.39299999999143E-06 |
| Grade 1-vs-Grade 2 |
3.695800E-01 |
| Grade 1-vs-Grade 3 |
1.498420E-01 |
| Grade 1-vs-Grade 4 |
4.326400E-01 |
| Grade 2-vs-Grade 3 |
6.230100E-02 |
| Grade 2-vs-Grade 4 |
9.790200E-01 |
| Grade 3-vs-Grade 4 |
2.615200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.22959486615582E-11 |
| Normal-vs-ccB subtype |
8.34610158761961E-11 |
| ccA subtype-vs-ccB subtype |
2.880400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62380117632688E-11 |
| Normal-vs-N1 |
4.267700E-02 |
| N0-vs-N1 |
7.731200E-01 |
|
|
